Northpond Ventures II, LP - Sep 30, 2025 SCHEDULE 13G/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, par value $0.0001 per share (CAMP)

Filing Manager
Northpond Ventures II, LP
Reporting Manager
Michael P. Rubin
Security
CAMP4 THERAPEUTICS CORPORATION Common Stock, par value $0.0001 per share
Symbol
CAMP
Shares outstanding
46.6M shares
Disclosed Ownership
2.24M shares
Ownership
4.8%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:49 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Northpond Ventures II, LP 2.1% 1M 0 1M /s/ Patrick Smerkers By Northpond Ventures II GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures II GP, LLC 2.1% 1M 0 1M /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Northpond Ventures III, LP 1.6% 764K 0 764K /s/ Patrick Smerkers By Northpond Ventures III GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures III GP, LLC 1.6% 0 0 764K /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Northpond Ventures, LP 1% 471K 0 471K /s/ Patrick Smerkers By Northpond Ventures GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures GP, LLC 1% 471K 0 471K /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Michael P. Rubin 4.8% 2.24M 0 2.24M /s/ Michael P. Rubin Michael P. Rubin